HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Plasma and dried blood spot lysosphingolipids for the diagnosis of different sphingolipidoses: a comparative study.

Abstract
Background Lysosphingolipids, the N-deacylated forms of sphingolipids, have been identified as potential biomarkers of several sphingolipidoses, such as Gaucher, Fabry, Krabbe and Niemann-Pick diseases and in GM1 and GM2 gangliosidoses. To date, different methods have been developed to measure various lysosphingolipids (LysoSLs) in plasma. Here, we present a novel liquid chromatography tandem mass spectrometry (LC-MS/MS) assay for a simultaneous quantification of LysoSLs (HexSph, LysoGb3, LysoGM1, LysoGM2, LysoSM and LysoSM509) in dried blood spot (DBS). This LC-MS/MS method was used to compare the levels of LysoSLs in DBS and plasma in both affected patients and healthy controls. Methods Lysosphingolipids were extracted from a 3.2 mm diameter DBS with a mixture of methanol:acetonitrile:water (80:15:5, v/v) containing internal stable isotope standards. Chromatographic separation was performed using a C18 column with a gradient of water and acetonitrile both with 0.1% formic acid in a total run time of 4 min. The compounds were detected in the positive ion mode electrospray ionization (ESI)-MS/MS by multiple reaction monitoring (MRM). Results The method was validated on DBS to demonstrate specificity, linearity, lowest limit of quantification, accuracy and precision. The reference ranges were determined in pediatric and adult populations. The elevated levels of LysoSLs were identified in Gaucher disease (HexSph), Fabry disease (LysoGb3), prosaposin deficiency (HexSph and LysoGb3) and Niemann-Pick disease types A/B and C (LysoSM and LysoSM509). The correlation in the levels between DBS and plasma was excellent for LysoGb3 and HexSph but poor for LysoSM and LysoSM509. Conclusions Despite the fact that plasma LysoSLs determination remains the gold standard, our LC-MS/MS method allows a rapid and reliable quantification of lysosphingolipids in DBS. The method is a useful tool for the diagnosis of different sphingolipidoses except for Niemann-Pick type C.
AuthorsGiulia Polo, Alessandro P Burlina, Enzo Ranieri, Francesca Colucci, Laura Rubert, Antonia Pascarella, Giovanni Duro, Albina Tummolo, Andrea Padoan, Mario Plebani, Alberto B Burlina
JournalClinical chemistry and laboratory medicine (Clin Chem Lab Med) Vol. 57 Issue 12 Pg. 1863-1874 (Nov 26 2019) ISSN: 1437-4331 [Electronic] Germany
PMID31091195 (Publication Type: Journal Article)
Chemical References
  • Biomarkers
  • Sphingolipids
Topics
  • Adolescent
  • Adult
  • Aged
  • Biomarkers (blood)
  • Child
  • Child, Preschool
  • Chromatography, Liquid (methods)
  • Dried Blood Spot Testing (methods)
  • Female
  • Humans
  • Infant
  • Infant, Newborn
  • Lysosomal Storage Diseases (blood, diagnosis)
  • Male
  • Middle Aged
  • Plasma (chemistry)
  • Reference Values
  • Reproducibility of Results
  • Sensitivity and Specificity
  • Sphingolipidoses (blood, diagnosis)
  • Sphingolipids (analysis, blood)
  • Tandem Mass Spectrometry (methods)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: